uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcome of extremities and trunk wall
Show others and affiliations
2011 (English)In: International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, Vol. 81, no 5, 1359-1366 p.Article in journal (Refereed) Published
Abstract [en]

Purpose: To evaluate adjuvant chemotherapy and interpolated accelerated radiotherapy (RT) for adult patients with high-risk soft tissue sarcoma in the extremities or trunk wall. Methods and Materials: High-risk soft tissue sarcoma was defined as high-grade malignancy and at least two of the following criteria: size >= 8 cm, vascular invasion, or necrosis. Six cycles of doxorubicin and ifosfamide were prescribed for all patients. RT to a total dose of 36 Gy (1.8 Gy twice daily) was inserted between two chemotherapy cycles after marginal margin resection regardless of tumor depth or after wide-margin resection for deep-seated tumors. RT was boosted to 45 Gy in a split-course design in the case of intralesional margin resection. Results: A total of 119 patients were eligible, with a median follow-up of 5 years. The 5-year estimate of the local recurrence, metastasis-free survival, and overall survival rate was 12%, 59%, and 68%, respectively. The group receiving RT to 36 Gy had a local recurrence rate of 10%. In contrast, the local recurrence rate was 29% in the group treated with RT to 45 Gy. The presence of vascular invasion and low chemotherapy dose intensity had a negative effect on metastasis-free and overall survival. Toxicity was moderate after both the chemotherapy and the RT. Conclusions: Accelerated RT interposed between chemotherapy cycles in a selected population of patients with high-risk soft tissue sarcoma resulted in good local and distant disease control, with acceptable treatment-related morbidity. The greater radiation dose administered after intralesional surgery was not sufficient to compensate for the poorer surgical margin. Vascular invasion was the most important prognostic factor for metastasis-free and overall survival.

Place, publisher, year, edition, pages
2011. Vol. 81, no 5, 1359-1366 p.
Keyword [en]
Soft tissue sarcoma, Adjuvant treatment, Accelerated radiotherapy, Chemotherapy, Prognostic factors
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-165617DOI: 10.1016/j.ijrobp.2010.07.037ISI: 000297602400022OAI: oai:DiVA.org:uu-165617DiVA: diva2:476934
Available from: 2012-01-12 Created: 2012-01-09 Last updated: 2012-01-12Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Turesson, Ingela
By organisation
In the same journal
International Journal of Radiation Oncology, Biology, Physics
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 129 hits
ReferencesLink to record
Permanent link

Direct link